FDA approves tropinetide for treatment of Rett syndrome

Published Date: 16 Mar 2023

The FDA has approved tropinetide (Daybue; Acadia Pharmaceuticals) to treat Rett syndrome in patients 2 years of age and older.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Colon cancer and exercise: Can physical activity reprogram genes?

2.

Distribution of fat could influence cancer risk, study suggests

3.

Effective for localizing small, non-palpable breast lesions is ultrasound-guided localization with magnetic seeds.

4.

EBV Screening Tied to Lower Nasopharyngeal Cancer Mortality Risk

5.

Women who miss their first mammogram face higher risk of breast cancer death, study finds


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot